Galmed Pharmaceuticals Ltd.
GLMD
$4.63
$0.8121.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.29% | -1.77% | 18.43% | 11.15% | 108.98% |
| Total Receivables | -25.40% | 0.89% | -61.72% | 28.87% | 220.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -42.33% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.27% | 2.46% | 2.48% | 4.20% | 4.24% |
| Total Current Assets | -44.45% | -1.66% | 15.52% | 11.53% | 109.25% |
|
|
|||||
| Total Current Assets | -44.45% | -1.66% | 15.52% | 11.53% | 109.25% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -20.31% | -14.22% | 0.69% | 3.03% | 71.98% |
|
|
|||||
| Total Accounts Payable | 38.57% | 31.80% | 53.13% | 24.74% | 13.80% |
| Total Accrued Expenses | -- | -- | -2.21% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -20.72% | -28.86% | -66.67% | -31.91% | 199.72% |
| Total Other Current Liabilities | -20.72% | -28.86% | -66.67% | -31.91% | 199.72% |
| Total Current Liabilities | 16.23% | 15.05% | 30.92% | -1.67% | 55.79% |
|
|
|||||
| Total Current Liabilities | 16.23% | 15.05% | 30.92% | -1.67% | 55.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 129.04% | 15.05% | 30.92% | -1.67% | 55.79% |
|
|
|||||
| Common Stock & APIC | 1.55% | 3.73% | 4.44% | 4.33% | 8.40% |
| Retained Earnings | -5.56% | -5.51% | -5.14% | -4.41% | -4.46% |
| Treasury Stock & Other | 17.87% | 3.53% | 27.16% | 7.60% | 7.36% |
| Total Common Equity | -37.93% | -17.35% | -3.34% | 3.67% | 74.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.93% | -17.35% | -3.34% | 3.67% | 74.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.93% | -17.35% | -3.34% | 3.67% | 74.12% |
|
|
|||||